LinkOPH

ANDOVER, Mass.–(BUSINESS WIRE)–Conjunctival Allergen Challenge model recently confirmed Phase 2 clinical results of Sustained Release Dexamethasone, a drug-eluting intracanalicular depot, under development by Ocular Therapeutix

Read more →

SAN FRANCISCO & LAS VEGAS–(BUSINESS WIRE)–DigiSight Technologies, Inc., a digital health company developing mobile solutions designed to engage patients and help physicians improve care and clinical outcomes, today announced the launch of a new suite of products at the 2015 Ophthalmology Innovation Summit (OIS@AAO) in Las Vegas. The Paxos™ portfolio of products includes a HIPAA-compliant cloud-based portal, a vision assessment smartphone application, a powerful mobile imaging device, and anal

Read more →

NEW YORK–(BUSINESS WIRE)–Ophthotech Corporation announced today that David R. Guyer, M.D., Chief Executive Officer and Chairman of the Board, will present an overview of the Company at the 2015 Stifel Healthcare Conference.

Read more →

ALPHARETTA, Ga.–(BUSINESS WIRE)–Clearside Biomedical, a clinical-stage biopharmaceutical company developing drug therapies for the eye, announces fifth patent issued in U.S. relating to its proprietary SCS™ drug delivery technology.

Read more →

LEXINGTON, Mass.–(BUSINESS WIRE)–Inotek Pharmaceuticals Corporation Reports Third Quarter 2015 Financial Results and Operational Highlights

Read more →